Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia

Background: Chinese medicine (CM) is widely used for treating hyperlipidemias, especially in China. However, the heterogeneity of outcomes measured and reported across trials exacerbates the obstacles of evidence synthesis and effectiveness comparison. In this study, we develop a core outcome set (C...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Geng Li (Dahkki), Ruxue Han (Dahkki), Mingjun Lin (Dahkki), Zehuai Wen (Dahkki), Xiankun Chen (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Frontiers Media S.A., 2022-05-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis